Thymulin
ExperimentalThymic nonapeptide / researchExperimental
Zinc-dependent thymic nonapeptide (FTS/thymulin) involved in T-cell differentiation. Not FDA-approved as a drug.
For research use only.
Key Facts
- CAS
- 63958-90-7
- Molecular Weight (MW)
- —
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- Research-dependent
- Last updated
- 8/23/2026
- Targets
- T-cell differentiation pathways
Overview
Zinc-dependent thymic nonapeptide (FTS/thymulin) involved in T-cell differentiation. Not FDA-approved as a drug.
Protocol
- Dosage Range
- Not established as a US drug
- Frequency
- Research-dependent
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
Science
Mechanism of Action
Requires zinc to adopt the active conformation; historically studied as a circulating thymic hormone that supports T-cell maturation.
Targets
T-cell differentiation pathways
Studies
- Thymulin / FTS review— Journal/year not available
Benefits
Thymic-hormone research
Potential Side Effects
- Limited modern safety data
References
- PMID 3537013External link · Year —